Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
QNRX
QNRX | US
4.57
USD0.08
1.78%
QNRX | US
Loading StockChartView...
About QNRX
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
08/06/2026
Close
4.57
Open
4.72
High
4.75
Low
4.33
Quoin Pharmaceuticals Ltd. a clinical stage specialty pharmaceutical company focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003 a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn Virginia.
View LessQNRX | US
Risk
55.2
Sharpe
-0.27
Luna's Score
42/100
Recommendation
Sell
Luna says (QNRX | US)
What's Working
Strength based on increasing price with high volume
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
56.6%1 month
55.2%3 months
92.0%6 months
103.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.45
Debt to equity
0.43
Debt to assets
0.23
Ent. to EBITDA
-0.42
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-8.84M
MarketCap
18.19M
MarketCap(USD)
18.19M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-100.03
Short ratio
0.01
Short perc.
0.38
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.04
Range1M
2.24
Range3M
6.72
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.10
Price X volume
157.50K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.42 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.45 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 92.00 | 72.80 | Riskier |
| Debt to Equity | 0.43 | -1.23 | Expensive |
| Debt to Assets | 0.23 | 0.25 | Par |
| Market Cap | 18.19M | 3.66B | Emerging |
